Specific Thiazolidinediones Inhibit Ovarian Cancer Cell Line Proliferation and Cause Cell Cycle Arrest in a PPARγ Independent Manner
2011

Thiazolidinediones Inhibit Ovarian Cancer Cell Growth

publication Evidence: moderate

Author Information

Author(s): Al-Alem Linah, Southard R. Chase, Kilgore Michael W., Curry Thomas E., Agoulnik Irina

Primary Institution: University of Kentucky College of Medicine

Hypothesis

Do thiazolidinediones (TZDs) affect ovarian cancer cell proliferation in a PPARγ dependent or independent manner?

Conclusion

CGZ and TGZ decrease ovarian cancer cell proliferation through a mechanism that is independent of PPARγ.

Supporting Evidence

  • Treatment with CGZ decreased proliferation by 80% in Ovcar3 cells.
  • TGZ caused a 65% decrease in cell proliferation.
  • Rosi and Pio had no effect on cell proliferation.
  • CGZ and TGZ increased apoptosis after 4 hours of treatment.

Takeaway

Some medicines called TZDs can help stop ovarian cancer cells from growing, and they do this without needing a specific protein called PPARγ.

Methodology

The study used ovarian cancer cell lines and treated them with different TZDs to measure cell proliferation and PPARγ activity.

Limitations

The study primarily focused on in vitro cell lines, which may not fully represent in vivo conditions.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0016179

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication